Pre-exposure prophylaxis (PrEP) by U.S. residents against HIV infection has resulted in positive outcomes. Incidence of new HIV infections among those 13 years old and above fell during 2012 - 2016, and this plunge presented a statistically noteworthy association with an increase in drug prophylaxis among U.S. residents in the same duration.
Epidiolex, compounded from decontaminated cannabidiol, or CBD, permitted for two atypical types of epilepsy, would be the first prescription medication extracted from the marijuana plant, expected to reach pharmacies this fall.
In the medical field, no matter what kind of science or technological issue we are dealing with, laboratory equipment is essential for all researching, experimenting and measuring processes, hence, the efficiency and reliability of the laboratory equipment are to key the indexes we need to focus on.
Sun Pharma, India’s largest drugmaker, has launched Kapspargo Sprinkle in the US. This drug is used in the treatment of heart failure, chest pain, and high blood pressure.
Findings from two international, randomized, double-blind, phase III, placebo-controlled trials published in the September issue of Gastroenterology revealed that the oral second-generation thrombopoietin agonist avatrombopag (Doptelet) when given once a day, notably decreased the requirement for platelet transfusion...
The extended deal with DSM offers Aerie an elite worldwide license to DSM’s polyesteramide polymer technology for a limitless number of drugs in any ophthalmic indication and also an exposure to DSM’s preclinical latanoprost implant created for people with glaucoma. The two companies have spanned their partnership till the end of 2020, as per Aerie.
$7.6 million has been granted to SkinVision, an Amsterdam-based skin cancer screening app, as backing from active investors Leo Pharma and PHS Fund, with supplementary aid from unnamed new sponsors which the company called "high net worth impact investors."
The condition of memory loss is termed as Alzheimer’s disease, affecting more than 5 million people and there is still no definite cure. A research team reported that an experimental drug could treat Alzheimer’s disease by slowing down the process of clear thinking and memory.
A week post Bayer’s announcement on the withdrawal of Essure, its contraceptive implant from the market by this year-end due to inadequate sales, its clinical safety is questioned as consumer and legal stress builds up concerning complaints of extreme fatigue, pain and bleeding.
A phase 2 study on BAN2401, a monoclonal antibody that hits soluble amyloid beta oligomers, showed that it limits cognitive decline in patients with slight cognitive injury or premature Alzheimer’s dementia on two scales and removed brain amyloid in 81% of patients in the trial.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.